{
    "2018-09-04": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Geron Stock Up More Than 200% in 2018 So Far: Here's Why",
                "features": {
                    "keywords": [
                        "Geron",
                        "Stock",
                        "Up",
                        "200%",
                        "2018"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-31",
                "original_text": "How Eli Lillyâ€™s Elanco Performed in Q2 2018",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Elanco",
                        "Q2",
                        "2018"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}